Details for Patent: 6,951,639
✉ Email this page to a colleague
Title: | 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
Abstract: | 1,4,7,10-Tetraazacyclodedecane butyltriols of general formula I.sub.A ##STR1## in which R.sup.1 means hydrogen or a metal ion equivalent independent of one another and R.sup.2 means a butyltriol radical as well as their salts with organic or inorganic bases or amino acids are valuable pharmaceutical agents. |
Inventor(s): | Platzek; Johannes (Berlin, DE), Gries; Heinz (Berlin, DE), Weinmann; Hanns-Joachim (Berlin, DE), Schuhmann-Giampieri; Gabriele (Berlin, DE), Press; Wolf-Rudiger (Berlin, DE) |
Assignee: | Schering AG (Berlin, DE) |
Filing Date: | Apr 09, 2002 |
Application Number: | 10/118,430 |
Claims: | 1. A method of performing in vivo NMR spectroscopy in a patient comprising administering a compound as a susceptibility agent which has the formula I.sub.A ##STR8## in which each R.sup.1 is hydrogen or a metal ion equivalent, independent of one another and R.sup.2 is butyltriol or a salt thereof with an organic or inorganic base or an amino acid, and at least two of the substitutens R.sup.1 are metal ion equivalents. 2. A method of radiation therapy of a patient comprising administering as a photon and electron emitting agent, a compound which has the formula I.sub.A ##STR9## in which each R.sup.1 is hydrogen or a metal ion equivalent, independent of one another and R.sup.2 is butyltriol or a salt thereof with an organic or inorganic base or an amino acid, and at least two of the substitutens R.sup.1 are metal ion equivalents. |